Evaluation and modification of French screening guidelines for retinopathy of prematurity. Issue 7 (26th January 2022)

• Record Type: Journal Article
• Authors: Barjol, Amandine; Lux, Anne Laure; Dureau, Pascal; Chapron, Thibaut; Metge, Florence; Abdelmassih, Youssef; Caputo, Georges
• Is Part Of: Acta ophthalmologica. Volume 100:Issue 7(2022)
• Page Start: e1451
• Page End: e1454
• Publication Date: 2022-01-26
• Subjects: laser photocoagulation -- retinopathy of prematurity -- screening -- treatment; Ophthalmology -- Periodicals; 617.7005
• DOI: 10.1111/aos.15091
• Languages: English
• ISSNs: 1755-375X

Abstract

Abstract: Purpose: To evaluate the current French screening guidelines for retinopathy of prematurity (ROP) and to suggest modifications to it. Methods: In this multicentric retrospective, noncomparative, interventional case series we included infants with a gestational age (GA) ≤32 weeks who were screened for ROP by fundus examination between 2011 and 2018. Main Outcome Measures were the presence of ROP and the need for treatment. Results: A total of 2246 children with a mean GA of 28.9 ± 2.0 weeks and mean birth weight (BW) of 1141.1 ± 332.0 g were screened. Retinopathy of prematurity (ROP) was found in 683 infants (30.4%), of whom 145 (6.5%) had type 2 ROP and 58 (2.6%) had type 1 ROP. Mean GA of infants with type 1 ROP needing treatment was 25.9 + 1.5 weeks (range: 23.6–30) and mean BW was 774.1 ± 173.7 g (range: 540–1400). Both GA and BW had an impact on the development of type 1 and 2 ROP. None of the infants needing treatment had a GA of 31 weeks or more. None of the children needed treatment before 33 weeks of postmenstrual age (PMA) or 6 weeks of postnatal age (PNA). Conclusion: It seems possible to decrease the screening of premature infants to ≤31 weeks of GA and to start screening at 31 weeks PMA for infants having a GA < 26 weeks and at 6 weeks PNA for more mature children.